Disclosure as enclosed

August 17, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir/Madam, Sub: Record Date for payment of Final Dividend for Financial Year 2025-26 Ref: Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) In continuation to our intimation on outcome of the Board Meeting held on May 25, 2026, pertaining to recommendation of Final Dividend @40% i.e. ₹2.00/- per Equity Share of ₹5/- each for the FY 2025-26, please note that the Company has fixed Tuesday, September 15, 2026 as the ‘Record Date’ for payment of Final Dividend for the Financial Year 2025-26. The Final Dividend will be paid to the Members whose names appear in the Register of Members of the Company as on the Record Date, as above, if approved by the Shareholders in the ensuing Annual General Meeting scheduled to be held on Tuesday, September 22, 2026. Accordingly, the dividend will be paid on or before Tuesday, October 20, 2026. Please take the same on your records. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565